Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 72
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Clin Exp Immunol ; 161(3): 471-9, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20636398

RESUMO

Chronic inflammation as a risk factor for cancer development is driven in part by monocyte/macrophages, which in many cancers exhibit pro-tumorigenic activity. In this study we identified elevation in CD14(+) CD16(+) , a minor blood monocyte subpopulation in cholangiocarcinoma (CCA) patients, compared to normal and biliary disease patient specimens. Tumour association was suggested by the observation that this elevated level decreased to normal after tumour resection. Moreover, the elevated level of CD14(+) CD16(+) monocytes in CCA patient blood correlated with degree of MAC387-positive (recent blood-derived macrophage migrant-specific marker) tumour-associated macrophage infiltration as determined by immunohistochemistry. These CD14(+) CD16(+) monocytes were suggested to enhance tumour progression as this subpopulation possesses (i) high expression of adhesion molecules (CD11c, CD49d, and CD54) and scavenger receptor (CD163), which enable them to adhere strongly to endothelial cells, and (ii) that peripheral blood monocytes from CCA patients express high levels of growth and angiogenic factor-related genes (epiregulin, VEGF-A and CXCL3). Elevation of peripheral CD14(+) CD16(+) monocyte levels was associated with features associated with poor prognosis CCA parameters (non-papillary type and high number of tissue macrophages). These data indicate that the CD14(+) CD16(+) monocytes from CCA patients with pro-tumorigenic characteristics may associate with rapid tumour progression and poor patient outcome. If confirmed in subsequent studies, the level of CD14(+) CD16(+) monocytes may serve as a marker for disease activity in CCA patients and serve as a target for pathogenic macrophage specific drug development.


Assuntos
Neoplasias dos Ductos Biliares/sangue , Ductos Biliares Intra-Hepáticos , Colangiocarcinoma/sangue , Receptores de Lipopolissacarídeos/sangue , Monócitos/metabolismo , Receptores de IgG/sangue , Neoplasias dos Ductos Biliares/genética , Neoplasias dos Ductos Biliares/patologia , Células Cultivadas , Quimiocina CXCL10/genética , Quimiocinas CXC/genética , Colangiocarcinoma/genética , Colangiocarcinoma/patologia , Feminino , Citometria de Fluxo , Regulação Neoplásica da Expressão Gênica , Humanos , Estimativa de Kaplan-Meier , Masculino , Pessoa de Meia-Idade , Monócitos/patologia , Valor Preditivo dos Testes , Prognóstico , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fator A de Crescimento do Endotélio Vascular/genética
2.
Science ; 232(4754): 1123-7, 1986 May 30.
Artigo em Inglês | MEDLINE | ID: mdl-3010463

RESUMO

The formation of multinucleated giant cells with progression to cell death is a characteristic manifestation of the cytopathology induced by the AIDS retrovirus in infected T lymphoid cells. The mechanism of giant cell formation was studied in the CD4 (T4/Leu 3) positive T cell lines JM (Jurkat) and VB and in variants of these lines that are negative for cell surface CD4 antigen. By means of a two-color fluorescent labeling technique, multinucleated giant cells in infected cultures were shown to form through cell fusion. Antibody to CD4 specifically inhibited fusion, and uninfected CD4 negative cells, in contrast to uninfected CD4 positive cells, did not undergo fusion with infected cells, suggesting a direct role for the CD4 antigen in the process of syncytium formation. These results suggest that, in vivo, cell fusion involving the CD4 molecule may represent a mechanism whereby uninfected cells can be incorporated into AIDS virus infected syncytia. Because the giant cells die soon after they are formed, this process may contribute to the depletion of helper/inducer T cells characteristically observed in AIDS.


Assuntos
Síndrome da Imunodeficiência Adquirida/patologia , Antígenos de Superfície/imunologia , Antígenos Virais/imunologia , Deltaretrovirus/imunologia , Linfócitos T/patologia , Síndrome da Imunodeficiência Adquirida/imunologia , Síndrome da Imunodeficiência Adquirida/microbiologia , Antígenos de Diferenciação de Linfócitos T , Imunofluorescência , Linfócitos T/imunologia , Linfócitos T/microbiologia
3.
J Clin Invest ; 87(2): 503-12, 1991 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-1671392

RESUMO

We wanted to establish an in vitro human model for AIDS-associated dementia and pursue the hypothesis that this disease process may be a result of soluble factors produced by HIV-infected macrophages. Human brain aggregates were prepared from nine different brain specimens, and were treated with supernatants from in vitro HIV-infected macrophages (SI), uninfected macrophages (SU), infected T cells, or macrophage-conditioned media from four AIDS patients. Seven of nine treated brains exposed to SI showed peripheral rarefaction after 1 wk of incubation that by ultrastructural analysis showed cytoplasmic vacuolation. Aggregates from two of three brain cultures treated with SI for 3 wk became smaller, an approximately 50% decrease in size. The degree of apparent toxicity in brains exposed to patient-derived macrophage supernatants paralleled the proportion of macrophages found to be expressing HIV p24. Ultrastructural abnormalities were not observed in brains treated with supernatants from HIV-infected T cells, uninfected macrophages, or LPS-activated macrophages. Levels of five neurotransmitter amino acids were decreased in comparison to the structural amino acid leucine. These findings suggest that HIV-infected macrophages, infected both in vitro as well as derived from AIDS patients' peripheral blood, produce factors that cause reproducible histochemical, ultrastructural, and functional abnormalities in human brain aggregates.


Assuntos
Complexo AIDS Demência/patologia , Encéfalo/patologia , HIV/isolamento & purificação , Macrófagos/microbiologia , Complexo AIDS Demência/metabolismo , Western Blotting , Encéfalo/metabolismo , Encéfalo/microbiologia , Células Cultivadas , Humanos , L-Lactato Desidrogenase/análise , Lipopolissacarídeos/farmacologia , Macrófagos/metabolismo , Microscopia Eletrônica , Neurônios/ultraestrutura , Neurotransmissores/análise , Azul Tripano/análise
4.
J Clin Invest ; 82(6): 2097-105, 1988 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-3264291

RESUMO

Infection of monocyte-macrophages with human immunodeficiency virus may be central to the pathogenesis of the acquired immunodeficiency syndrome. The ability of infected macrophages to prime T cells through IL-1 production was investigated in vitro. Purified human monocytes maintained in suspension culture were infected with strain HIV-DV. Intracellular expression of virus p24 antigen increased from undetectable levels immediately after infection to 13-59% of cells by 10-14 d; infected macrophages remained viable for up to 60 d. Supernatants collected between 14 and 20 d after infection were examined in the murine thymocyte co-mitogenesis assay and demonstrated to contain a potent IL-1 inhibitor, designated contra-IL-1. Contra-IL-1 activity was present in all supernatants examined after 4 d of infection, and peaked coincident with peak p24 antigen expression. Inhibitory activity was not present in uninfected cells. Contra-IL-1 activity eluted after gel filtration with an approximate molecular weight of 9 kD. Inhibitory activity was removed by exposure to heat or acid pH, or by incubation with chymotrypsin or staphylococcal V8 protease. Contra-IL-1 did not inhibit IL-2- or IL-4-dependent proliferation of murine T cell lines. Despite its ability to inhibit IL-1 activity, contra-IL-1 did not interfere with the binding of recombinant IL-1 beta to a fibroblast cell line. Contra-IL-1 inhibited the proliferation of normal peripheral blood mononuclear cells to both concanavalin A and tetanus toxoid; inhibition could be attenuated by the addition of exogenous IL-1. Messenger RNA extracted from infected macrophages was examined by Northern analysis for the presence of message to IL-1 beta. No message was apparent, suggesting that the presence of contra-IL-1 was not obscuring the concomitant release of IL-1. Infected macrophages stimulated with endotoxin generated readily detectable message for IL-1 beta. Spleen macrophages purified from two patients with AIDS complicated by immune thrombocytopenia spontaneously expressed p24 antigen in vitro and released contra-IL-1 activity into the media. Contra-IL-1 may contribute to the immune dysfunction of AIDS.


Assuntos
Síndrome da Imunodeficiência Adquirida/imunologia , Interleucina-1/antagonistas & inibidores , Linfocinas/metabolismo , Macrófagos/imunologia , Células Cultivadas , Quimotripsina , Humanos , Interleucina-2/metabolismo , Interleucina-4 , Interleucinas/metabolismo , Macrófagos/microbiologia , Monócitos/imunologia , RNA Mensageiro/metabolismo , Serina Endopeptidases , Linfócitos T/imunologia
5.
Infect Genet Evol ; 51: 194-197, 2017 07.
Artigo em Inglês | MEDLINE | ID: mdl-28392467

RESUMO

HIV cure research is increasingly focused on anatomical tissues as sites for residual HIV replication during combined antiretroviral therapy (cART). Tissue-based HIV could contribute to low-level immune activation and viral rebound over the course of infection and could also influence the development of diseases, such as atherosclerosis, neurological disorders and cancers. cART-treated subjects have a decreased and irregular presence of HIV among tissues, which has resulted in a paucity of actual evidence concerning how or if HIV persists, replicates and evolves in various anatomical sites during therapy. In this study, we pooled 1806 HIV envelope V3 loop sequences from twenty-six tissue types (seventy-one total tissues) of six pre-cART subjects, four subjects with an unknown cART history who died with profound AIDS, and five subjects who died while on cART with an undetectable plasma viral load. A computational approach was used to assess sequences for their ability to utilize specific cellular coreceptors (R5, R5 and X4, or X4). We found that autopsied tissues obtained from virally suppressed cART+ subjects harbored both integrated and expressed viruses with similar coreceptor usage profiles to subjects with no or ineffective cART therapy (i.e., significant plasma viral load at death). The study suggests that tissue microenvironments provide a sanctuary for the continued evolution of HIV despite cART.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Microambiente Celular/imunologia , Infecções por HIV/imunologia , Evasão da Resposta Imune , Neoplasias/imunologia , Receptores CCR5/genética , Receptores CXCR4/genética , Terapia Antirretroviral de Alta Atividade , Autopsia , Biologia Computacional , Feminino , Expressão Gênica , Infecções por HIV/complicações , Infecções por HIV/tratamento farmacológico , Infecções por HIV/patologia , HIV-1/genética , HIV-1/crescimento & desenvolvimento , HIV-1/imunologia , Humanos , Masculino , Neoplasias/complicações , Neoplasias/tratamento farmacológico , Neoplasias/patologia , Receptores CCR5/imunologia , Receptores CXCR4/imunologia , Análise de Sequência de RNA , Carga Viral/imunologia , Produtos do Gene env do Vírus da Imunodeficiência Humana/genética , Produtos do Gene env do Vírus da Imunodeficiência Humana/imunologia
6.
Cancer Res ; 54(8): 2069-72, 1994 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-8174106

RESUMO

Infection with human immunodeficiency virus type 1 (HIV-1) is associated with a high incidence of lymphoma. Typically, the lymphomas are B-cell in origin, and although they occur in the setting of HIV-1 infection, historical studies have found no evidence for the presence of HIV-1 within the transformed B-cells. We describe a new class of large cell lymphoma wherein HIV p24 expression within the tumor specimens was found to be extremely high. In the first case, HIV was expressed in the tumor-associated transformed T-cells. In three other cases, HIV was found to be highly expressed in tumor-associated macrophages. These tumors exhibited a mixed immunophenotype histologically. Analysis by inverse polymerase chain reaction, using HIV long terminal repeat primers, demonstrated monoclonal HIV integration sites for all four tumors. Direct sequencing of the T-cell lymphoma inverse polymerase chain reaction products identified the HIV integration site within the fur gene, just upstream from the c-fes/fps protooncogene. Using segments of the fur gene as a probe, the other three monoclonal integration sites mapped to the same region. Although the integration and up-regulation of c-fes/fps was localized to the tumor cells within the T-cell lymphoma, the cells containing the monoclonal HIV in the other mixed immunophenotype lymphomas are currently unknown. These observations suggest that HIV may contribute directly to lymphomagenesis and identify a common site of HIV integration within a subset of acquired immunodeficiency syndrome lymphoma.


Assuntos
HIV-1/genética , Linfoma Relacionado a AIDS/genética , Linfoma Relacionado a AIDS/microbiologia , Proto-Oncogenes , Integração Viral , Sequência de Bases , Primers do DNA , Humanos , Imunofenotipagem , Linfoma Relacionado a AIDS/imunologia , Linfoma Relacionado a AIDS/patologia , Linfoma de Células B/genética , Linfoma de Células B/microbiologia , Linfoma de Células B/patologia , Dados de Sequência Molecular , Sondas de Oligonucleotídeos , Reação em Cadeia da Polimerase , Proteínas Tirosina Quinases/genética , Proteínas Proto-Oncogênicas/genética , Proteínas Proto-Oncogênicas c-fes , Mapeamento por Restrição
7.
J Leukoc Biol ; 56(3): 318-27, 1994 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8083603

RESUMO

HIV-1 infection of peripheral blood monocyte-derived macrophages (MDMs) is unrelated to the level of CD4 expression on the surface of the cell, is associated with considerable donor variability, causes minimal cytopathology, and results in peak viral antigen production after 2 weeks of infection. Phagocytosis of opsonized Candida albicans by MDMs infected in vitro with several strains of HIV was compared with that of uninfected cells from the same donors; the proportion of MDMs containing the fluorescein isothiocyanate-labeled yeast was determined by flow cytometry and phase contrast microscopy. The intracellular localization of C. albicans was confirmed by confocal microscopy. Using paired MDMs from nine donors, 81% of uninfected and 53% of HIV-infected MDMs phagocytosed C. albicans. In addition, the number of yeast per cell was significantly higher in uninfected MDMs than in HIV-infected cells (mean 6.1 versus 2.5). These findings may partially explain the high incidence of mucocutaneous candidiasis in HIV-infected patients with advanced disease.


Assuntos
Síndrome da Imunodeficiência Adquirida/fisiopatologia , Candida albicans/imunologia , Macrófagos/microbiologia , Macrófagos/patologia , Monócitos/citologia , Fagocitose/fisiologia , Infecções Oportunistas Relacionadas com a AIDS/complicações , Infecções Oportunistas Relacionadas com a AIDS/epidemiologia , Síndrome da Imunodeficiência Adquirida/complicações , Síndrome da Imunodeficiência Adquirida/patologia , Complexo CD3/análise , Complexo CD3/fisiologia , Antígenos CD4/análise , Antígenos CD4/fisiologia , Candidíase/complicações , Candidíase/epidemiologia , Diferenciação Celular , Células Cultivadas , Suscetibilidade a Doenças , Citometria de Fluxo , Fluoresceína-5-Isotiocianato , HIV-1/isolamento & purificação , Humanos , Incidência , Macrófagos/fisiologia , Monócitos/imunologia
8.
AIDS ; 5(10): 1237-42, 1991 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-1786150

RESUMO

A formulated preparation of trichosanthin (GLQ223, Pharmaceutical Development Group, Genelabs Inc., Redwood City, California, USA) has been shown to selectively inhibit HIV replication in vitro in lymphocytes and macrophages. In view of recent anecdotal reports of central nervous system (CNS) complications associated with trichosanthin use in some HIV-infected patients, we evaluated any potential drug effects leading to neurotoxicity using a human brain cell aggregate model. Brain cell aggregate cultures were incubated with dilutions of purified trichosanthin alone (trichosanthin), supernatants of HIV-infected macrophage cultures (S-HIV), supernatants of uninfected macrophage cultures (S-U), supernatants of purified trichosanthin-treated uninfected macrophage cultures (S-trichosanthin), or supernatants of purified trichosanthin-treated HIV-infected macrophage cultures (S-HIV-trichosanthin). Treatment with purified trichosanthin alone at up to 2 micrograms/ml, with S-U or with S-trichosanthin, produced no morphological signs of toxicity to brain cell aggregate cultures. S-trichosanthin treatment at 2 micrograms/ml did not result in a significant change in cyclic nucleoside phosphorylase (CNP) activity. Treatment of the brain aggregates with S-HIV and S-HIV-trichosanthin did, however, result in morphological alteration of the brain aggregates, with S-HIV-trichosanthin-treated brain aggregates showing the most severe damage. Although purified trichosanthin did not appear to be directly toxic to human brain aggregate cultures, trichosanthin treatment of infected macrophages may have increased the morphological alterations caused by supernatants of HIV-infected macrophages. These experimental observations may explain anecdotal reports of adverse CNS reactions in association with trichosanthin treatment of HIV-infected patients and emphasize the neurotoxic potential of any therapy targeted at HIV-infected macrophages.


Assuntos
Encéfalo/efeitos dos fármacos , Infecções por HIV/complicações , Tricosantina/efeitos adversos , Encéfalo/enzimologia , Células Cultivadas , Humanos , Macrófagos/enzimologia , Macrófagos/patologia , Microscopia Eletrônica , Monócitos/enzimologia , Monócitos/patologia
9.
AIDS ; 8(8): 1025-49, 1994 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-7986399

RESUMO

The AIDS-associated lymphomas represent a heterogeneous set of disease processes. The largest histologic subset of lymphomas is the large-cell lymphomas, which represent a spectrum of disease processes ranging from monomorphic monoclonal B-cell proliferations to very polymorphic and polyclonal mixtures of B cells, T cells and macrophages. The next most frequent class of systemic lymphoma are the small non-cleaved cell or Burkitt's-like lymphomas. These are relatively monomorphic, monoclonal malignant B-cell proliferations. The final subset of lymphomas, which are likely to become more common as the AIDS epidemic progresses, are the primary CNS lymphomas, which are expansions of EBV-immortalized B cells. The high incidence of tumor-associated EBV in the CNS lymphomas makes these lesions somewhat analogous to an opportunistic EBV infection. In HIV disease there is a long lag after infection before the appearance of clinical manifestations of impaired T-cell immunity. During this period, both appropriate B-cell proliferation in response to antigen (including the ubiquitous HIV) and abnormal B-cell proliferation (autoimmune, dysregulated) occur as the follicular architecture is disrupted by the virus and potential APC are exposed and/or infected with HIV. The destruction of FDC or the involution of their processes could interfere with the elimination by apoptosis of low-avidity B-cell clones. Antigen-competent B cells with pre-existing chromosomal translocations such as the t(8;14) (c-myc, IgH) would have a selective growth advantage in this setting. Figure 9 shows a schematic representation of prelymphomatous and lymphomagenic events as they are projected to occur. A similar pathogenetic scheme has been postulated for follicular B-cell lymphomas: PCR studies have demonstrated that a pool of t(14;18) (IgH;bcl-2) B-cells are present in lymph nodes featuring follicular hyperplasia. In response to antigen (the evidence favoring antigen drive is extensive hypersomatic mutation in sequences related to binding sites), B cells with the t(14;18) translocation have a selective advantage because the bcl-2 oncogene confers a resistance to apoptosis. Burkitt's lymphomas, particularly sporadic or HIV variants, fulfill at least the key criteria for antigen competence, mainly the presence of surface Ig. The c-myc-associated chromosomal translocational events are likely to occur early during the enzymatic machinations of gene rearrangement. Such B cells would be in the dysregulated cytokine and antigen milieu of HIV disease and ultimately could have a selective advantage. EBV infection of B cells probably requires activation and expression of the CD21 receptor. Furthermore, CD5+ B cells of CLL are refractory to EBV infection.(ABSTRACT TRUNCATED AT 400 WORDS)


Assuntos
Síndrome da Imunodeficiência Adquirida/complicações , Infecções por HIV/complicações , Linfoma de Células B/complicações , Linfoma/complicações , Diagnóstico Diferencial , Humanos , Linfoma/diagnóstico , Linfoma/epidemiologia , Linfoma/fisiopatologia , Linfoma de Células B/diagnóstico , Linfoma de Células B/epidemiologia , Linfoma de Células B/fisiopatologia , Estados Unidos/epidemiologia
10.
AIDS ; 10(13): 1495-500, 1996 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-8931783

RESUMO

OBJECTIVE: To determine whether or not soluble factors produced by peripheral blood mononuclear cells (PBMC) can predict AIDS dementia. DESIGN AND METHODS: PBMC were isolated from individuals with and without AIDS dementia complex (ADC) to determine if the levels of cytokines tumour necrosis factor (TNF)-alpha and interleukin (IL)-6, or the production of a neurotoxic substance, were significantly different. PBMC were studied after determining that the numbers of monocyte-derived macrophages isolated by adherence were highly variable from patients with ADC compared with individuals without ADC. We prospectively studied 16 AIDS dementia patients, 13 healthy HIV-seropositive individuals, and eight sero-negative controls. Supernatants from PBMC were assayed for TNF-alpha, IL-6 and alone for neurotoxicity on human neural cells in vitro. RESULTS: We observed a trend towards worse cognitive and motor performance in patients suffering from ADC but who had no opportunistic infections ('pure dementia'; n = 8). Levels of PBMC IL-6 were significantly higher in 'pure dementia' patients. There was a trend towards lower levels of PBMC TNF-alpha in the group of patients who had both dementia and opportunistic infections compared with "pure dementia' patients. Supernatant from PBMC of ADC patients was significantly more neurotoxic than that from healthy HIV-seropositive individuals. CONCLUSIONS: Macrophage isolation from PBMC of patients with ADC was altered. Soluble factors produced from PBMC were significantly more neurotoxic than soluble factors from PBMC of healthy HIV-seropositive individuals. PBMC production of TNF-alpha and IL-6 was not a significant predictor of ADC.


Assuntos
Complexo AIDS Demência/imunologia , Soropositividade para HIV/imunologia , Interleucina-6/imunologia , Leucócitos Mononucleares/imunologia , Neurotoxinas/toxicidade , Fator de Necrose Tumoral alfa/imunologia , Complexo AIDS Demência/sangue , Adulto , Encéfalo/citologia , Sobrevivência Celular , Células Cultivadas , Estudos de Coortes , Soronegatividade para HIV/imunologia , Soropositividade para HIV/sangue , Humanos , Leucócitos Mononucleares/citologia , Masculino , Pessoa de Meia-Idade , Monocinas/imunologia , Estudos Prospectivos
11.
J Interferon Cytokine Res ; 15(3): 261-8, 1995 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-7584673

RESUMO

Cytokine expression was examined by reverse transcriptase-polymerase chain reaction (RT-PCR) in a retrospective sampling of 16 AIDS-associated large cell lymphomas (LCL). IL-6 receptor (IL-6R) and IL-10 expression was detected in a majority of the tumor specimens tested, IL-6 expression was detected in 5 of 16 lymphomas that also expressed IL-6R, suggestive of an autocrine mechanism of disease. A subset of tumor samples described as mixed immunophenotype contained large numbers of infiltrating T lymphocytes and macrophages. Immunoperoxidase staining of a representative tumor of mixed immunophenotype demonstrated the presence of HIV-infected macrophages that also stained with anti-IL-6. This finding suggests that IL-6 produced by nonlymphoid cells may act as a paracrine growth factor for tumor cells that express IL-6R. Although earlier studies of AIDs burkitt's lymphoma cell lines suggested that IL-10 expression required EBV infection, 7 of 12 AIDS LCLs that expressed IL-10 did so in the absence of EBV by EBER in situ hybridization. Because AIDS LCLs frequently express cell surface CD5, we speculate that IL-10 may act as an autocrine or paracrine growth factor for this class of lymphoma. These studies suggest that IL-6 and IL-10 are involved in the pathogenesis of AIDS-associated large cell and mixed immunophenotype lymphoma.


Assuntos
Citocinas/biossíntese , Herpesvirus Humano 4/isolamento & purificação , Linfoma Relacionado a AIDS/imunologia , Linfoma Difuso de Grandes Células B/imunologia , Sequência de Bases , Citocinas/genética , Herpesvirus Humano 4/genética , Humanos , Técnicas Imunoenzimáticas , Interleucina-10/biossíntese , Interleucina-10/genética , Interleucina-6/biossíntese , Interleucina-6/genética , Linfócitos do Interstício Tumoral/imunologia , Linfoma Relacionado a AIDS/complicações , Linfoma Relacionado a AIDS/virologia , Linfoma Difuso de Grandes Células B/complicações , Linfoma Difuso de Grandes Células B/virologia , Dados de Sequência Molecular , RNA/biossíntese , RNA Viral/análise , Estudos Retrospectivos
12.
Artigo em Inglês | MEDLINE | ID: mdl-2666640

RESUMO

Zidovudine (3'-azido-3'deoxythymidine, AZT, Retrovir) is the first antiretroviral drug to demonstrate clinical efficacy for symptomatic human immunodeficiency virus infection. In a large, placebo-controlled trial, nausea and hematologic toxicity, but not fever, occurred more frequently in zidovudine- than in placebo-treated patients. However, in an open label study, fever severe enough to halt zidovudine administration occurred in 10% of 70 acquired immune deficiency syndrome (AIDS) patients receiving the drug. We now describe three AIDS patients with severe zidovudine-induced fever in whom other causes of fever were excluded. Zidovudine-induced fever was confirmed in each case by drug rechallenge. Using an enzyme immunoassay, we detected IgM antibodies directed against a zidovudine-serum protein conformational determinant in one of these three patients. Neither IgG nor IgM anti-zidovudine antibodies were present in sera from the other two patients with zidovudine fever, from four AIDS patients who discontinued zidovudine for reasons other than fever, or from five AIDS patients who never received zidovudine. Zidovudine may cause fever as a severe adverse effect in patients with AIDS. Either type III or type IV hypersensitivity may mediate this reaction.


Assuntos
Síndrome da Imunodeficiência Adquirida/tratamento farmacológico , Febre/induzido quimicamente , Zidovudina/efeitos adversos , Adulto , Anticorpos/análise , Complexo Antígeno-Anticorpo/análise , Enzimas Ativadoras do Complemento , Complemento C1 , Complemento C1q , Humanos , Técnicas Imunoenzimáticas , Imunoglobulina G/análise , Imunoglobulina M/análise , Masculino , Zidovudina/imunologia
13.
Artigo em Inglês | MEDLINE | ID: mdl-1848889

RESUMO

High-grade non-Hodgkins B-cell lymphoma is one of the principle malignancies that occurs in individuals infected with the human immunodeficiency virus (HIV-1). Immunoblastic lymphomas that arise in immunosuppressed transplant patients have been described as both monoclonal and polyclonal, and occur in association with Epstein-Barr virus (EBV) infection. To test whether polyclonal lymphoma occurred in patients with AIDS we studied tumors from multiple sites in three patients who died with widespread AIDS-associated large cell or large cell immunoblastic lymphoma. All biopsy specimens contained invasive lymphoma. Tumor cells were mature IgM-positive immunoblasts by immunohistochemical analysis, with the same B-cell phenotype observed in all tumor sites. Only a minority of sites from all patients analyzed were monoclonal as measured by immunoglobulin gene rearrangements, with one case having several foci of monoclonal disease with other histologically identical metastases showing no evidence of monoclonal proliferation. Similar to the transplant-associated polyclonal B-cell proliferations. EBV gene sequences were present in multiple sites from one autopsy. In the other two autopsies, polyclonal B-cell proliferations occurred in the absence of EBV involvement except at one site, where a minor clone of EBV-infected cells was found. In contrast to HIV-associated Burkitt's lymphoma, no c-myc rearrangements were found at any site. These studies describe the occurrence of polyclonal lymphoma in AIDS and suggest that EBV-negative polyclonal lymphoma may be a distinct disease entity unique to HIV-infected individuals.


Assuntos
Síndrome da Imunodeficiência Adquirida/complicações , Linfoma Difuso de Grandes Células B/complicações , Adulto , Southern Blotting , DNA Viral/análise , Neoplasias de Cabeça e Pescoço/complicações , Neoplasias de Cabeça e Pescoço/patologia , Herpesvirus Humano 4/genética , Humanos , Neoplasias Pulmonares/complicações , Neoplasias Pulmonares/patologia , Linfoma Difuso de Grandes Células B/patologia , Masculino , Pessoa de Meia-Idade
14.
J Acquir Immune Defic Syndr (1988) ; 7(6): 560-70, 1994 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-7513761

RESUMO

Oligonucleotide compounds composed of only deoxyguanosine and deoxythymidine were able to significantly inhibit human immunodeficiency virus type -1 (HIV-1)-induced syncytium formation and virus production (as measured by p24 core antigen expression) in an acute infection assay system. The oligonucleotides did not share any homology with or possess any complementary (antisense) sequence motifs to the HIV-1 genome. The guanosine/thymidine-containing oligonucleotides (GTOs) that showed this anti-HIV activity contained natural phosphodiester (PD) linkages (backbones) between the nucleosides. One of the PD oligonucleotide sequence motifs tested was capable of inhibiting HIV-1-induced syncytium formation and p24 production with a median effective dose in culture (ED50) in the submicromolar range. In addition, oligonucleotides tested were able to significantly suppress HIV-1 p24 levels > or = 7 days after removal of the drug from the infected cell culture medium. The growth inhibition properties (toxicity) of this genre of oligonucleotides was determined to be well above the ED50 values yielding high selective indexes. In vitro results showed that GTOs with PD backbones were potent competitive inhibitors of HIV-1 reverse transcriptase. These same molecules were capable of blocking the interaction between gp120 and CD4. All measured activities of these molecules were increased by factors of 10-500 when the PD backbone was replaced with a PT backbone in a sequence-dependent manner. The enhanced antiviral activity displayed by the sulfur group on the oligonucleotide backbone and the lack of any sequence-specific interactions suggest that a percentage of antiviral activity of oligonucleotide-based therapeutics is due to mechanisms other than those originally postulated for oligonucleotides. The good selective index of GTOs coupled with the prolonged suppression of HIV-1 in culture after removal of oligonucleotides from the infected cell culture make this a class of compounds that warrant investigation as therapeutic agents to be used against HIV-1.


Assuntos
Guanosina/química , HIV-1/efeitos dos fármacos , Oligonucleotídeos/farmacologia , Timidina/química , Animais , Anticorpos Monoclonais/imunologia , Sequência de Bases , Ligação Competitiva , Antígenos CD4/imunologia , Divisão Celular/efeitos dos fármacos , Linhagem Celular , Células Gigantes/efeitos dos fármacos , Proteína do Núcleo p24 do HIV/biossíntese , Proteína do Núcleo p24 do HIV/efeitos dos fármacos , Proteína gp120 do Envelope de HIV/imunologia , Transcriptase Reversa do HIV , HIV-1/imunologia , HIV-1/fisiologia , Humanos , Dados de Sequência Molecular , Oligonucleotídeos/química , Fragmentos de Peptídeos/imunologia , Inibidores da Transcriptase Reversa , Células Vero
15.
J Immunol Methods ; 211(1-2): 79-86, 1998 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-9617833

RESUMO

Primary cultured human macrophages are difficult to transfect. We have developed a DEAE-dextran DNA transfection method that mediates the reproducible transfection of primary cultured adherent human macrophages. Three factors essential for successful transfection were identified: DEAE-dextran concentration, the quantity of DNA per transfection and the incubation time of the macrophages with the transfection medium. Maximum levels of luciferase expression were attained within 24 h and maintained for at least 56 h after transfection. While serum in the transfection medium attenuated transfection, the treatment of the macrophages with chloroquine, DMSO, or glycerol did not enhance transfection within this system. A CMV enhancer/promoter mediated substantially greater luciferase expression in the macrophages than either HIV or RSV LTRs. DEAE-dextran facilitated superior transfection compared to either cationic liposome and calcium phosphate methods, and was more practical compared to electroporation for multiple transfections. This transfection protocol provides a simple, inexpensive, reproducible method for the evaluation of gene expression in primary cultured adherent human macrophages.


Assuntos
Macrófagos , Transfecção/métodos , Adulto , Vírus do Sarcoma Aviário , Adesão Celular , Células Cultivadas , Cloroquina , Meios de Cultura , Citomegalovirus/genética , Dextranos , Dimetil Sulfóxido , Relação Dose-Resposta a Droga , Etanolaminas , Expressão Gênica , Genes Reporter , Vetores Genéticos , Glicerol , Repetição Terminal Longa de HIV , Humanos , Luciferases/genética , Macrófagos/citologia , Macrófagos/metabolismo , Regiões Promotoras Genéticas , Fatores de Tempo
16.
Viral Immunol ; 3(2): 99-109, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-1694432

RESUMO

One potential strategy for the control of human immunodeficiency virus (HIV) infection is immune network manipulation using anti-idiotypic antibodies: this study was undertaken to demonstrate experimentally the potential of such an approach which, in a more highly evolved form, could be used for the treatment of the acquired immune deficiency virus (AIDS) and related disorders. Anti-idiotypic antibodies were generated in rabbits against a murine monoclonal antibody identifying an epitope on the p24 gag core protein of HIV. After extensive absorption on affinity columns to remove isotype- and allotype-specific antibodies, the purified anti-idiotypic antibody preparation was shown to have specific complementarity with the immunizing mouse monoclonal antibody. This anti-idiotypic antibody was also shown to recognize a common idiotype associated with HIV-specific antibodies from both humans and chimpanzees infected with the AIDS virus. In addition a group of rats immunized with the anti-Id responded with significant antibody titers to recombinant derived p24 gag. These data indicate that at least a subpopulation of these polyclonal anti-Id antibodies structurally mimics an HIV gag region epitope and suggest that immunoregulation by anti-idiotypic antibodies may have therapeutic utility for the AIDS epidemic.


Assuntos
Anticorpos Anti-Idiotípicos/imunologia , Epitopos/imunologia , Produtos do Gene gag/imunologia , Anticorpos Anti-HIV/imunologia , Proteínas do Core Viral/imunologia , Animais , Anticorpos Anti-Idiotípicos/administração & dosagem , Anticorpos Anti-Idiotípicos/biossíntese , Anticorpos Monoclonais/imunologia , Western Blotting , Reações Cruzadas , Proteína do Núcleo p24 do HIV , Infecções por HIV/imunologia , Idiótipos de Imunoglobulinas/imunologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Pan troglodytes , Coelhos , Ratos , Especificidade da Espécie
17.
AIDS Res Hum Retroviruses ; 6(8): 1039-43, 1990 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-2223240

RESUMO

GLQ223 is a formulated version of tricosanthin, a single-chain ribosome-inactivating protein that was shown in earlier studies to inhibit human immunodeficiency virus (HIV) replication in T-lymphoblastoid cells and to decrease HIV p24 levels in HIV-infected monocyte-derived macrophages as measured by flow cytometry. The current studies were performed to test the selectivity of the observed inhibitory effects on HIV replication in chronically infected macrophages infected in vitro. Peripheral blood-derived monocyte/macrophages were infected in vitro and cultivated in suspension for at least two weeks prior to GLQ223 treatment. Anti-HIV effects were quantitated by measurement of cytoplasmic HIV p24, by both enzyme-linked immunosorbent assay (ELISA) and flow cytometry and HIV RNA levels were measured by slot blot analysis. Incorporation of [3H]leucine into trichloroacetic acid- (TCA) precipitable protein was also evaluated as an index of nonspecific inhibitory effects mediated by the compound in infected and uninfected cultures. Five days after a single 3-h treatment with GLQ223 there was a concentration-dependent decrease in all measurable HIV parameters within infected cultures. The anti-HIV effects persisted at least 28 days without evidence for increasing HIV expression. GLQ223 treatment of parallel uninfected macrophage cultures showed no significant inhibition of tritiated leucine uptake. These experiments demonstrate that a single pulsed exposure with GLQ223 of macrophages infected with HIV in vitro caused a sustained, concentration-dependent decrease in both HIV p24 antigen levels as well as HIV RNA without causing measurable toxicity in uninfected cultures.


Assuntos
Antivirais/farmacologia , Infecções por HIV/tratamento farmacológico , HIV/efeitos dos fármacos , Macrófagos/microbiologia , Monócitos/microbiologia , Tricosantina/farmacologia , Antivirais/administração & dosagem , Relação Dose-Resposta a Droga , HIV/crescimento & desenvolvimento , Humanos , Técnicas In Vitro , Macrófagos/efeitos dos fármacos , Monócitos/efeitos dos fármacos , Tricosantina/administração & dosagem , Replicação Viral/efeitos dos fármacos
18.
AIDS Res Hum Retroviruses ; 3(2): 135-45, 1987.
Artigo em Inglês | MEDLINE | ID: mdl-3113464

RESUMO

HIV infection of CD4-bearing lymphocytes alone does not fully explain the immune dysfunction of AIDS. Monocyte/macrophages infected with HIV may serve as a reservoir of HIV, may function abnormally and may transmit infection to other susceptible cells, thus playing a central role in the development of the immunodeficiency of AIDS. Quantitative analysis of surface antigens and measurement of HIV antigens in infected cells have been difficult using the conventional approach of immunofluorescent staining of cells on slides. We have developed a system that maintains monocyte/macrophages in suspension culture for at least four months. Through immunocytofluorographic single cell analysis we have shown that CD4 antigen is present on monocytes, and that a tenfold increase in expression occurs during the first two weeks in culture. In contrast, LeuM3 antigens decreased to background levels in the course of long-term culture. Using anti-HIV p24 antibody, we have demonstrated that monocyte/macrophages can be infected with HIV. Up to 70% of cells from individual donors could be infected. The techniques herein described allow in vitro quantitation of some of the mechanisms by which HIV infection of monocyte/macrophages may contribute to the immunodeficiency states associated with AIDS.


Assuntos
Antígenos de Superfície/análise , Antígenos Virais/análise , HIV/crescimento & desenvolvimento , Macrófagos/microbiologia , Monócitos/microbiologia , Anticorpos Monoclonais , Antígenos de Diferenciação de Linfócitos T , Células Cultivadas , HIV/imunologia , Humanos , Técnicas In Vitro , Macrófagos/imunologia , Monócitos/imunologia
19.
AIDS Res Hum Retroviruses ; 6(8): 1031-7, 1990 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-1977427

RESUMO

Human immunodeficiency virus-(HIV) infected monocyte-macrophages may contribute to the pathogenesis of HIV-associated immune deficiency and dysfunction by acting as a target and potential reservoir for the virus in vivo, and by functioning abnormally following infection. We have shown that HIV-infected macrophages fuse with uninfected CD4-expressing lymphoid cells in vitro; this may provide an additional mechanism for CD4 lymphocyte depletion in vivo. We report here the inhibition of syncytium formation between HIV-infected macrophages and uninfected CD4-expressing T-lymphoid cells by monoclonal antibody S3.5, directed against an epitope of CD4 involved in binding HIV gp120, by a recombinant protein that comprises the full-length extracellular domain of the CD4 molecule, and by recombinant full-length HIV envelope glycoprotein, gp120. These results indicate that both molecules (gp120 and CD4) are critical to the fusion process, and suggest that gp120 is expressed on the surface of HIV-infected monocyte-macrophages.


Assuntos
Antígenos CD4/farmacologia , Linfócitos T CD4-Positivos/fisiologia , Fusão Celular , Proteína gp120 do Envelope de HIV/farmacologia , Infecções por HIV/etiologia , Macrófagos/fisiologia , Monócitos/fisiologia , Anticorpos Monoclonais/imunologia , Linfócitos T CD4-Positivos/ultraestrutura , Células Cultivadas , Infecções por HIV/imunologia , Infecções por HIV/patologia , Humanos , Depleção Linfocítica , Macrófagos/ultraestrutura , Monócitos/ultraestrutura , Proteínas Recombinantes/farmacologia , Solubilidade
20.
AIDS Res Hum Retroviruses ; 13(2): 135-49, 1997 Jan 20.
Artigo em Inglês | MEDLINE | ID: mdl-9007199

RESUMO

The pathogenesis of polyclonal HIV-associated lymphomas lacking traditional B cell cofactors (i.e., Epstein-Barr virus [EBV] infection, c-myc translocations) is poorly understood. A multistep pathogenesis model has been proposed in which polyclonal lymphomas represent an earlier stage in HIV-associated lymphomagenesis before the emergence of a dominant malignant clone. Chronically present antigens have been proposed as a likely stimulus for polyclonal B cell proliferation; if so, polyclonal lymphoma-associated immunoglobulins (Igs) should have molecular evidence of somatic hypermutation, a process by which antibody affinity maturation in response to chronic antigenic stimulation occurs. Molecular analyses of Ig heavy chain variable (V(H)) gene use by B cells in a polyclonal HIV-associated large cell lymphoma lacking EBV and c-myc rearrangement was undertaken. Eighteen randomly selected clones generated from RT-PCR yielded 15 unique V(H) sequences, all of which were most homologous to only three previously identified germline V(H)1 genes. Two sets of clones (consisting of three and two clones, respectively) had identical V(H) gene sequences, and one pair of clones had identical third complementarity determining regions (CDR3s) but different V(H) gene sequences; eight clones were <95% homologous to their most related germline V(H)1 genes. We compared these results with Ig V(H)1 gene use by B cells present in a reactive hyperplastic lymph node obtained from an HIV-1-infected individual. Fifteen clones randomly selected from RT-PCRs yielded 15 unique V(H)1 sequences, all of which were most homologous to 5 previously identified germline V(H)1 genes; 10 clones were <95% homologous to their most related germline gene. Binomial probability analysis revealed that only 1 of the 15 unique V(H)1 sequences derived from the polyclonal lymphoma (i.e., 7%), as compared with 5 of 15 unique V(H)1 sequences derived from the reactive lymph node (i.e., 33%), had a low probability of occurrence by random chance (p < 0.05). These data provide molecular evidence of polyclonality in an HIV-associated polyclonal lymphoma, demonstrate a qualitative difference in somatic hypermutations of Ig V(H) genes associated with malignant versus reactive B cell lymphoproliferations, and support an antigen-mediated multistep pathogenesis model of HIV-1-associated lymphomagenesis.


Assuntos
Infecções por HIV/imunologia , HIV-1/imunologia , Cadeias Pesadas de Imunoglobulinas/genética , Região Variável de Imunoglobulina/genética , Linfoma Relacionado a AIDS/imunologia , Sequência de Aminoácidos , Antígenos CD/análise , Sequência de Bases , Southern Blotting , DNA Viral , Infecções por HIV/genética , Infecções por HIV/patologia , Humanos , Linfoma Relacionado a AIDS/genética , Linfoma Relacionado a AIDS/patologia , Dados de Sequência Molecular , Homologia de Sequência do Ácido Nucleico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA